Fabry disease is a rare genetic disorder caused by a defective gene (the GLA gene) in the body. In most cases, the defect in the gene causes a deficient quantity of the enzyme alpha-galactosidase A. This enzyme is necessary for the daily breakdown (metabolism) of a lipid (fatty substance) in the body called globotriaosylceramide abbreviated GL-3 or GB-3. When proper metabolism of this lipid and other similar lipids does not occur, GL-3 accumulates in the majority of cells throughout the body. The resulting progressive lipid accumulation leads to cell damage. The cell damage causes a wide range of mild to severe symptoms including potentially life-threatening consequences such as kidney failure, heart attacks and strokes often at a relatively early age. Fabry disease is a progressive, destructive and potentially life-threatening disease. Fabry disease can affect males and females of all ethnic and cultural backgrounds.

The image to the right is a representation of the X-chromosome with the location of the Fabry gene annotated in red - loci Xq 22.1

There are many different descriptions of Fabry disease in print and electronic media depending on the focus of the literature. Some of the various terminologies used include:

  • A multi-system disorder: There are many common simultaneous effects of Fabry disease on multiple bodily systems.
  • A lysosomal storage disorder: Lipid (GL-3/GB-3) accumulates in the lysosomes which function as the cells' recycling/housekeeping centers.
  • A metabolic disorder: An inborn error of metabolism whereby the GL-3/GB-3 lipid is not properly metabolized, thus disrupting normal metabolic function.
  • A hereditary or congenital disease: Congenital is synonymous with hereditary. Fabry disease is a genetic disease which is passed from a parent to a child. Fabry disease may also appear in a family as an initial (de novo) spontaneous gene mutation.
  • An X-linked disorder: The defective Fabry gene is located on the X chromosome, which is one of the two chromosomes that determine an individual's sex.
  • An error of glycosphingolipid metabolism: The lipid GL-3 is a glycosphingolipid which refers to the chemical composition of the lipid.

See other topics in the About Fabry tab for more information about Fabry disease.

We Need Your Help

As a IRS 501(c)(3) non-profit support organization we rely on donations from organizations and individuals to provide meaningful support and assistance programs to people/families with Fabry disease. Please give generously!  

DonateNow

Thank you to our corporate and foundation sponsors as well as our many individual donors. Contributions of all sizes add up to make a tremendous difference.

Connect With Us